Venous Stents Market to Hit $2.62 Billion by 2033, Driven by Minimally Invasive Surgery & Vascular Innovation

Leander, Texas and Tokyo, Japan - Dec.05.2025
As per DataM intelligence research report" The Global Venous Stents Market reached US$ 1.24 billion in 2024 and is expected to reach US$ 2.62 billion by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033." Rising cardiovascular disease prevalence and minimally invasive interventions are boosting venous stent demand.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/venous-stents-market?Prasad

United States: Recent Industry Developments

✅ In November 2025, InterVene received FDA 510(k) clearance for its Recana system for venous obstruction While not a stent itself the device prepares the vein for stenting or restoration improving outcomes It offers a new tool for treating deep vein thrombosis sequelae in the U.S.

✅ In November 2025, Cook Medical released 12-month data from a trial of its dedicated venous stent for IVC obstruction The data showed high patency rates and low migration risk in complex venous anatomy It supports the long-term safety of venous stenting for U.S. patients

✅ In September 2025, Becton Dickinson (BD) launched a larger diameter version of its Venovo venous stent The new size is designed to treat obstructions in the larger iliac and femoral veins It expands the treatable patient population for venous disease in the U.S.

✅ In August 2025, Medtronic initiated a post-market study to track the durability of its Abre venous self-expanding stent The study aims to gather real-world evidence on stent performance in active patients It reinforces the commitment to evidence-based venous care in the U.S.

Japan: Recent Industry Developments

✅ In December 2025, Terumo Corporation launched a new drug-eluting venous stent in the Japanese market The stent releases an anti-thrombotic drug to prevent clots from forming inside the device It addresses the high risk of re-thrombosis in Japanese patients with DVT

✅ In October 2025, The Japanese Society of Phlebology updated its guidelines to recommend stenting for May-Thurner Syndrome The guidelines clarify the indications for stenting versus conservative therapy It standardizes the treatment of iliac vein compression in Japan

✅ In September 2025, Boston Scientific Japan received approval for a specialized delivery system for its venous stent The system allows for more precise placement of the stent in tortuous veins It improves the success rate of venous interventions in Japanese hospitals

✅ In July 2025, A Japanese university hospital published a study on the long-term patency of venous stents in Asian patients The findings suggest slight differences in healing response compared to Western populations It contributes to localized clinical knowledge for venous treatment in Japan

Venous Stents Market: Drivers
The venous stents market is growing as cardiovascular diseases and venous insufficiency become more prevalent globally. These minimally invasive devices restore blood flow, prevent vein collapse, and improve patient quality of life. Advancements in biocompatible materials, drug-eluting coatings, and self-expanding designs are enhancing safety and efficacy. Rising awareness of venous disease treatment options and early intervention strategies is driving adoption. Increasing hospital procedures, outpatient interventions, and cardiovascular diagnostics further strengthen market growth.

Collaborations between medical device manufacturers, healthcare providers, and research institutions accelerate innovation in venous stent technology. Growth in minimally invasive procedures, interventional radiology, and outpatient surgical centers expands application areas. Integration with imaging guidance systems and post-procedural monitoring platforms improves treatment outcomes. Rising investment in cardiovascular healthcare infrastructure and patient education supports market expansion. With continuous technological advancements and growing disease prevalence, the venous stents market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/venous-stents-market?Prasad

Venous Stents Market: Major Players
Medtronic Plc, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Becton, Dickinson and Company (BD), Abbott Laboratories, Cordis Corporation(Cardinal Health), Vesper Medical, Bentley, Optimed Medizinische Instrumente GmbH and among others.

Segment Covered in the Venous Stents Market:
By Product Type
Self-expanding venous stents lead with 45% share, driven by their flexibility, ease of deployment, and suitability for complex venous anatomies. Balloon-expandable stents hold 30%, used primarily in targeted venous interventions requiring precise placement. Covered stents capture 15%, preferred for treating occluded or damaged veins. Drug-eluting stents account for 7%, offering reduced restenosis risk. Other specialty stents contribute 3%, supporting niche applications and emerging minimally invasive procedures.

By Material
Nitinol dominates with 50% share due to its shape-memory properties, biocompatibility, and wide usage in self-expanding stents. Stainless steel holds 28%, used for balloon-expandable stents and cost-effective solutions. Cobalt-chromium alloys account for 15%, offering high radial strength and corrosion resistance. Other materials contribute 7%, including polymer-based or bioresorbable stents for specific applications. These materials collectively enable durable, safe, and effective venous interventions.

By Application
Peripheral venous disease leads with 40% share, driven by increasing prevalence of deep vein thrombosis (DVT) and chronic venous insufficiency. Renal and iliac vein stenosis account for 25%, requiring stent implantation for maintaining venous patency. Other venous obstructions contribute 20%, including portal vein and superior vena cava interventions. Post-thrombotic syndrome represents 10%, where stents aid in symptom relief. Emerging applications capture 5%, expanding the therapeutic scope of venous stents.

By End-User
Hospitals dominate with 60% share, leveraging interventional radiology and vascular surgery units for stent implantation. Specialty clinics hold 25%, offering minimally invasive treatments for venous diseases. Ambulatory surgical centers contribute 10%, performing selective procedures. Other end-users account for 5%, including research and academic institutions conducting clinical trials. Adoption is fueled by advanced infrastructure, skilled surgeons, and growing patient awareness.

Regional Analysis
North America leads with 35% share, driven by high prevalence of venous disorders, advanced healthcare infrastructure, and rapid adoption of minimally invasive procedures in the U.S. and Canada. Europe holds 28%, supported by Germany, France, and the UK, with strong interventional radiology adoption and reimbursement support. Asia Pacific captures 25%, led by China, Japan, South Korea, and India, fueled by growing patient population and increasing healthcare investments. South America holds 7%, adoption primarily in Brazil and Argentina for advanced vascular interventions. Middle East & Africa account for 5%, driven by early adoption in UAE, Saudi Arabia, and South Africa, with increasing healthcare awareness and infrastructure expansion.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=venous-stents-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.